(Q35718544)

9 August 2017

1 reference

title

Therapeutic effects of coenzyme Q10 in neurodegenerative diseases (English)

1 reference

9 August 2017

0 references

1 reference

1

M Flint Beal

1 reference

PubMed ID

15047118

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

9 August 2017

Methods in Enzymology

1 reference

9 August 2017

382

1 reference

9 August 2017

473-487

1 reference

Regulation of ubiquinone metabolism

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Mitochondrial encephalomyopathy with coenzyme Q10 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Familial cerebellar ataxia with muscle coenzyme Q10 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q-responsive Leigh's encephalopathy in two sisters

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q10, exercise lactate and CTG trinucleotide expansion in myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

The treatment of mitochondrial myopathies and encephalomyopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Protective action of idebenone against excitotoxic degeneration in cultured cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Restricted uptake of dietary coenzyme Q is in contrast to the unrestricted uptake of alpha-tocopherol into rat organs and cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Effects of coenzyme Q10 and alpha-tocopherol administration on their tissue levels in the mouse: elevation of mitochondrial alpha-tocopherol by coenzyme Q10.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Dietary coenzyme Q10 and vitamin E alter the status of these compounds in rat tissues and mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing rat

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Tissue coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Distribution and breakdown of labeled coenzyme Q10 in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

The reaction of nitric oxide with ubiquinol: kinetic properties and biological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Succinate-ubiquinone reductase linked recycling of α-tocopherol in reconstituted systems and mitochondria: Requirement for reduced ubiquinone

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Kinetic study of free-radical-scavenging action of biological hydroquinones (reduced forms of ubiquinone, vitamin K and tocopherol quinone) in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Comparative study on dynamics of antioxidative action of alpha-tocopheryl hydroquinone, ubiquinol, and alpha-tocopherol against lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q10 enrichment decreases oxidative DNA damage in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q is an obligatory cofactor for uncoupling protein function

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Uncoupling proteins 2 and 3 are highly active H(+) transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

A Ubiquinone-binding Site Regulates the Mitochondrial Permeability Transition Pore

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Decreased ubiquinone levels in tissues of rats deficient in selenium

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Selenium deficiency and decreased coenzyme Q levels

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Ubiquinone is reduced by lipoamide dehydrogenase and this reaction is potently stimulated by zinc

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Reduction of ubiquinone by lipoamide dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Effect of coenzyme Q(10) on biochemical and morphological changes in experimental ischemia in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Assessment of coenzyme Q10 tolerability in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Spinocerebellar ataxias due to mitochondrial defects

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Inhibition of Fe-S cluster biosynthesis decreases mitochondrial iron export: evidence that Yfh1p affects Fe-S cluster synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Physical evidence that yeast frataxin is an iron storage protein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Antioxidant enzymes in blood of patients with Friedreich's ataxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Oxidative stress in patients with Friedreich ataxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Glutathione in blood of patients with Friedreich's ataxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2982026-3

7 January 2021

10.1016/S0076-6879(04)82026-3

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

15047118